Startups

Insilico Medicine receives strategic investment from Chinese biotech firm

The investment from WuXi AppTec includes a strategic partnership

Insilico Medicine relies on machine learning. (Courtesy photo)

Baltimore-based Insilico Medicine landed a new strategic investment from Chinese biotech company WuXi AppTec.
The amount of the funding was not disclosed, but the investment also includes a strategic partnership between Insilico and WuXi, which specializes in contract research for the pharmaceutical and medical device industries.
Based at ETC’s Eastern campus, Insilico Medicine seeks to bring artificial intelligence and other technology to the process of identifying new potential pharmaceutical treatments, which is known as drug discovery. Before the investment, Insilico had already begun working with WuXi. Now, WuXi has agreed to test molecules identified by the Insilico’s technology. It enables Insilico to complete testing without investing in laboratory infrastructure, said CEO Alex Zhavoronkov.
“With the investment in Insilico Medicine, we are now taking our partnership to the next level by establishing a closer integration within WuXi AppTec’s own research capabilities to better serve the biopharmaceutical industry,” Edward Hu, Chief Financial Officer and Chief Investment Officer of WuXi AppTec, said in a statement.  “We have been looking to collaborate with artificial intelligence-enabled technologies to enhance the drug discovery and development process.
WuXi’s venture arm led the round, which also included participation from Pavilion Capital, BOLD Capital Partners and existing Insilico Medicine partner Juvenescence. The company previously raised $14 million, per Crunchbase.

Before you go...

Please consider supporting Technical.ly to keep our independent journalism strong. Unlike most business-focused media outlets, we don’t have a paywall. Instead, we count on your personal and organizational support.

3 ways to support our work:
  • Contribute to the Journalism Fund. Charitable giving ensures our information remains free and accessible for residents to discover workforce programs and entrepreneurship pathways. This includes philanthropic grants and individual tax-deductible donations from readers like you.
  • Use our Preferred Partners. Our directory of vetted providers offers high-quality recommendations for services our readers need, and each referral supports our journalism.
  • Use our services. If you need entrepreneurs and tech leaders to buy your services, are seeking technologists to hire or want more professionals to know about your ecosystem, Technical.ly has the biggest and most engaged audience in the mid-Atlantic. We help companies tell their stories and answer big questions to meet and serve our community.
The journalism fund Preferred partners Our services
Engagement

Join our growing Slack community

Join 5,000 tech professionals and entrepreneurs in our community Slack today!

Trending

The person charged in the UnitedHealthcare CEO shooting had a ton of tech connections

From rejection to innovation: How I built a tool to beat AI hiring algorithms at their own game

Where are the country’s most vibrant tech and startup communities?

The looming TikTok ban doesn’t strike financial fear into the hearts of creators — it’s community they’re worried about

Technically Media